The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
When is Blythe drill due?
Well that explains why we are still under 40p with them selling into rises. Be interesting to see how much stock MM's are holding in the morning. That fund was prob balancing the books from the teens. Either way SP free to move now and just in time for contract deadline end of the month. Gotta love how things work on AIM.
Anyone have any idea how long FXPO can rely on its reserves to meet demand? I assume the power supply is still limited which is materially affecting profits and production? Ref RNS 1st November.
There haven't been any TR1's to suggest this has happened here. More likely to do with the dividend and bond payouts. The company was sitting on around 45% cash value in June against the current market cap and the payments from April, May, and June are still to reflect on the balance sheet - don't forget oil was higher over that period! Cash build-up is fast here, hence they have been able to pay so much out. This is a popular stock with retail investors, many of who are on a free ride from their buys 18months or so ago. Just think every month there is c$45-48million net going to GKP, so around $12m per week.
Depends on the investment strategy but this is really cheap.
Cash position will be strong and it will be good to be debt free. c$48million a month net coming through to GKP, June payment will average over $120 per barrel! The cash adds up quickly. Probably close to another $180m since the last Shaikan Payments Update (in June for sales in March). SP is around 12p higher than last December despite another c$300m net to GKP. That is a serious amount of cash.
Dividend Payment
At Gulf Keystone's 2022 Annual General Meeting on 24 June 2022, the Company's shareholders approved an annual ordinary dividend of $25 million.
Is the divident payment only for shareholders holding on or before 1st July 2022? My understanding is that you have until the ex div date to buy in which is next Wednesday? Thanks.
'The payment is equivalent to 11.561 US cents per Common Share of the Company. It has been converted into pounds sterling at a rate of $1:£0.8281 prevailing on 1 July 2022, and hence a dividend of 9.574p per Common Share will be paid on 15 July 2022 to those shareholders on the register of members of the Company as at 1 July 2022'.
Doesn't look like they sold as they were holding the same amount after the placing which completed in October. Looks like they just forgot to RNS they went sub 3% for 2 months due to the dilution. It took Calculus a while to update as well. Someone on Twitter spotted it. As he said institutions are still holding so no vencerns there then.
The Global Health Investment Fund (GHIF) was established to finance the development of new drugs, vaccines and diagnostics for public health challenges that disproportionately burden poor communities. ... Other notable GHIF investors include the International Finance Corporation, AXA, GSK, Merck and the Pfizer Foundation.
Also they only held 2.7m shares. They were showing 4.27% before the recent raise. They disappeared off the notifiable shareholder list because they went under 3% post raise. God knows why the TR1 says 4.27%. Unless they took part in the raise, in which case why did they no longer appear on the register. Something we'll never know on AIM.
But as others have said they sell out on their targets as most institutuins do.
The technology needs to be properly understood.
LFT's: Quick but lack accuracy and reliability and do people really use them properly when doing them themselves? Highly unlikely as you really have to stick the swabs in deep and I doubt many go the whole nine yards. Innova - the free ones we used to get were repackaged for home use and distribution by the NHS. A rubbish Chinese brand that was NEVER intended for use outside of a lab, let alone by a non-technician. 74% accuracy when in a lab, 54% accuracy when done at home. Near pointless. The government used them because there was a huge supply available and it allowed for consistency, albeit unreliable useless consistency.
PCR: much more accurate but the examination takes longer to get results, are generally sent away, use expensive chemicals, are processed in laboratories by highly trained staff, all of which present risk for cross contamination.
POC (This test) is Isothermal nucleic acid amplification and can deliver results on the spot (at the point of care) in 7.5 minutes allowing for real-time diagnosis. Isothermal Amplification = no need for the expensive thermocyclers which Traditional PCR’s use so absolutely perfect for all applications including lower-income countries. So basically you get the speed of LFT, combined with better accuracy than molecular PCR, IMMEDIATELY there and then. This is why Covid-19 POC diagnostics are becoming a more attractive test due to the fast delivery time of results. Unlike PCR and LFT, the POC market is NOT SATURATED.
Quote:
'The Company has resulted in designing and delivering a product with excellent performance specifications and a speed to result that is a new benchmark'. And that's why we have entities actively approaching GDR. The only other kit that comes close is the Abbot one, and that is currently the best seller.